HEPCLUVY Trademark

Trademark Overview

On Tuesday, October 26, 2021, a trademark application was filed for HEPCLUVY with the United States Patent and Trademark Office. The USPTO has given the HEPCLUVY trademark a serial number of 97093600. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, September 18, 2024. This trademark is owned by MYR GmbH. The HEPCLUVY trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hepatitis
hepcluvy

General Information

Serial Number97093600
Word MarkHEPCLUVY
Filing DateTuesday, October 26, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, September 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hepatitis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMYR GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressMartinsried 82152
DE
Party NameMYR GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressMartinsried 82152
DE

Trademark Events

Event DateEvent Description
Friday, October 29, 2021NEW APPLICATION ENTERED
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 3, 2022ASSIGNED TO EXAMINER
Wednesday, August 3, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 3, 2022NON-FINAL ACTION E-MAILED
Wednesday, August 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 23, 2023EXAMINER'S AMENDMENT ENTERED
Monday, January 23, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, January 23, 2023EXAMINERS AMENDMENT E-MAILED
Monday, January 23, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 23, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 6, 2023SOU EXTENSION 1 FILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 6, 2023SOU EXTENSION 1 GRANTED
Tuesday, April 2, 2024SOU EXTENSION 2 FILED
Tuesday, April 2, 2024SOU EXTENSION 2 GRANTED
Tuesday, April 2, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 18, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 18, 2024SOU EXTENSION 3 FILED
Wednesday, September 18, 2024SOU EXTENSION 3 GRANTED

Related Keywords

hepcluvy pharmaceutical preparations treatment disorders hepatitis diseases infective anti antiviral liver